Trachsel E - Search Results

1

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties.

Gafner V, Trachsel E, Neri D. Gafner V, et al. Among authors: trachsel e. Int J Cancer. 2006 Nov 1;119(9):2205-12. doi: 10.1002/ijc.22101. Int J Cancer. 2006. PMID: 16823838

2

Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis.

Trachsel E, Neri D. Trachsel E, et al. Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):735-54. doi: 10.1016/j.addr.2005.11.002. Epub 2006 May 20. Adv Drug Deliv Rev. 2006. PMID: 16822576 Review.

3

The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.

Kaspar M, Trachsel E, Neri D. Kaspar M, et al. Among authors: trachsel e. Cancer Res. 2007 May 15;67(10):4940-8. doi: 10.1158/0008-5472.CAN-07-0283. Cancer Res. 2007. PMID: 17510424

4

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.

Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak JN, Rösli C, Borsi L, Neri D. Villa A, et al. Among authors: trachsel e. Int J Cancer. 2008 Jun 1;122(11):2405-13. doi: 10.1002/ijc.23408. Int J Cancer. 2008. PMID: 18271006

5

Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.

Mårlind J, Kaspar M, Trachsel E, Sommavilla R, Hindle S, Bacci C, Giovannoni L, Neri D. Mårlind J, et al. Among authors: trachsel e. Clin Cancer Res. 2008 Oct 15;14(20):6515-24. doi: 10.1158/1078-0432.CCR-07-5041. Clin Cancer Res. 2008. PMID: 18927291

6

Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.

Fabbrini M, Trachsel E, Soldani P, Bindi S, Alessi P, Bracci L, Kosmehl H, Zardi L, Neri D, Neri P. Fabbrini M, et al. Among authors: trachsel e. Int J Cancer. 2006 Apr 1;118(7):1805-13. doi: 10.1002/ijc.21412. Int J Cancer. 2006. PMID: 16217760

7

Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19).

Spaeth N, Wyss MT, Pahnke J, Biollaz G, Trachsel E, Drandarov K, Treyer V, Weber B, Neri D, Buck A. Spaeth N, et al. Among authors: trachsel e. Nucl Med Biol. 2006 Jul;33(5):661-6. doi: 10.1016/j.nucmedbio.2006.05.001. Nucl Med Biol. 2006. PMID: 16843841

8

Ligand-based vascular targeting of disease.

Rybak JN, Trachsel E, Scheuermann J, Neri D. Rybak JN, et al. Among authors: trachsel e. ChemMedChem. 2007 Jan;2(1):22-40. doi: 10.1002/cmdc.200600181. ChemMedChem. 2007. PMID: 17154429 Review.

9

A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.

Trachsel E, Kaspar M, Bootz F, Detmar M, Neri D. Trachsel E, et al. J Invest Dermatol. 2007 Apr;127(4):881-6. doi: 10.1038/sj.jid.5700653. Epub 2006 Dec 21. J Invest Dermatol. 2007. PMID: 17185984 Free article.

10

Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.

Trachsel E, Bootz F, Silacci M, Kaspar M, Kosmehl H, Neri D. Trachsel E, et al. Arthritis Res Ther. 2007;9(1):R9. doi: 10.1186/ar2115. Arthritis Res Ther. 2007. PMID: 17261171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters